3 terminated, 1 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 3, Completed 1 |
Follow atamestane: new trials by email Literature Review of atamestane trials Research Report on atamestane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer Atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | Terminated | Intarcia Therapeutics | 200 | 2005-11-01 | 2007-09-10 |
| The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer Atamestane, Toremifene, Letrozole - Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | Terminated | Intarcia Therapeutics | 842 | 2004-12-01 | 2007-08-23 |
| Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer atamestane, toremifene, letrozole - Breast Neoplasms, Neoplasms, Hormone-dependent | Phase 3 | Completed | Intarcia Therapeutics | 865 | 2002-06-01 | 2015-07-31 |
| Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer atamestane, toremifene - Breast Cancer | Phase 3 | Terminated | Intarcia Therapeutics | 2000-10-01 | 2014-03-26 |
Breast Neoplasms (4) · Carcinoma, Ductal, Breast (3) · Carcinoma, Lobular (3) · Neoplasms, Hormone-Dependent (3)
United States (4) · Russia (3) · Ukraine (3) · Canada (2) · Bulgaria (1) · Romania (1)
Peter Langecker, MD, PhD (2) · Edith Perez, MD (1) · Paul Goss, M.D. (1)